Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nephrotoxicity Following 2-Stage Exchange With Associated Antibiotic Laden Spacer in Patients With Infected Total Hip/Knee Arthroplasty

NCT01683734 is registered in ClinicalTrials.gov with Central DuPage Hospital as lead sponsor.

NCT NCT01683734
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01683734 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nephrotoxicity Following 2-Stage Exchange With Associated Antibiotic Laden Spacer in Patients With Infected Total Hip/Knee Arthroplasty
Lead sponsor
Central DuPage Hospital
Phase
Observational
Overall status
Unknown status
Start date
May 31, 2012
Completion date
Not reported
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

infected total hip or knee arthroplasty